Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TSHA 120

Next Previous
Drug Profile

TSHA 120

Alternative Names: TSHA-120

Latest Information Update: 21 May 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator HANNAHS HOPE FUND
  • Developer Taysha Gene Therapies
  • Class Gene therapies
  • Mechanism of Action Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Giant axonal neuropathy
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Giant axonal neuropathy

Most Recent Events

  • 01 Jan 2024 Taysha Gene Therapies initiates the transfer of the US FDA IND application and investigational clinical trial material for TSHA 120 in giant axonal neuropathy to NINDS
  • 31 Dec 2023 Taysha Gene Therapies has patent protection for method of treatment with an rAAV vector comprising a transgene encoding gigaxonin, including methods of treating giant axonal neuropathy in USA
  • 19 Sep 2023 Taysha announces that Astellas Gene Therapies elects not to exercise its option to obtain an exclusive license to TSHA120 under the agreement

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top